Mirabegron CAS No.223673-61-8 Pharmaceutical Intermediates
Product detail
Mirabegron is a groundbreaking medication used in the treatment of overactive bladder (OAB), a condition characterized by an urgent need to urinate, frequent urination, and in some cases, urinary incontinence. Unlike traditional treatments that primarily use anticholinergic agents, Mirabegron operates through a unique mechanism as a beta-3 adrenergic agonist. This innovative approach allows for effective management of OAB symptoms while minimizing common side effects associated with anticholinergic medications. As a result, Mirabegron has become a preferred choice for both patients and healthcare providers seeking effective and well-tolerated treatment options.
product detail
|
CAS No. |
40856-44-8 |
|
EINECS |
609-874-3 |
|
Formula |
C9H11NO2 |
|
Molecular Weight |
165.19 |
|
Appearance |
White to Off-White solid |
|
Purity |
≥98% |
|
Type |
Pharmaceutical Intermediates |



